Radiotherapy and CTLA-4 blockade shape the TCR repertoire of tumor-infiltrating T cells
Rudqvist et al.
Cancer Immunology Research
Papers
November 2017
Authors and Affiliates
Nils-Petter Rudqvist1, Karsten A. Pilones1, Claire Lhuillier1, Erik Wennerberg1, John-William Sidhom2, Ryan O. Emerson3, Harlan S. Robins3,4, Jonathan Schneck2, Silvia C. Formenti1, Sandra Demaria1,5
1Department of Radiation Oncology, Weill Cornell Medicine, New York, NY 10065, USA, 2Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, MD, 3Adaptive Biotechnologies, 1551 Eastlake Ave. E, Seattle, WA 98102, USA, 4Public Health Sciences Division, Fred Hutchinson Cancer Research, 100 Fairview Ave. N., Seattle, WA 98109, USA, 5Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY 10065, USA